Archive in der Krebsforschung

  • ISSN: 2254-6081
  • H-Index der Zeitschrift: 13
  • Zitierbewertung der Zeitschrift: 3.58
  • Journal-Impact-Faktor: 3.12
Indiziert in
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • OCLC – WorldCat
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Google Scholar
  • Geheime Suchmaschinenlabore
Teile diese Seite

Abstrakt

The utilization of lung cancer screenings in relation to lung cancer risk and comorbidity

Ronald Ching

This study evaluated a distinct kind of antibody that is on little animate thing vesicles (sEVs), as a biomarker for early detection of carcinoma. The sEVs were isolated from plasma by centrifugation and valid with morphology and typical markers. The antibody levels were quantified by enzyme-linked immunosorbent assay, and more analysis indicated that the antibody panel on sEVs was higher than that from humour to differentiate benign respiratory organ illness (n = 32) from carcinoma (n = 90). Within the prospective study, antibody on sEVs performed higher in identification of patients with a better risk of carcinoma. What is more, with immunogold labeling transmission microscopy, Nanoflow cytometry and binding tests, we tend to illustrated that the autoantibodies may bind to the antigens on sEVs, which can justify the detected autoantibodies on sEVs. Besides, the binding resulted within the attenuation of complement-mediated toxicity, which can contribute to the immune escape of carcinoma.

Keywords: Lung cancer; tumor; Sarcoma; Carcinoma research

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert